EXELIXIS INC revenue breakdown overview

EXELIXIS INC revenue for the last year amounted to 1.97 B CHF, the most of which — 1.97 B CHF — came from its highest performing source at the moment, Medicines for Difficult-to-treat Cancers, the year earlier bringing 1.54 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought EXELIXIS INC 1.66 B CHF, and the year before that — 1.39 B CHF.